A detailed history of Aspen Investment Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aspen Investment Management Inc holds 8,364 shares of BMY stock, worth $444,881. This represents 0.17% of its overall portfolio holdings.

Number of Shares
8,364
Previous 8,464 1.18%
Holding current value
$444,881
Previous $459,000 24.4%
% of portfolio
0.17%
Previous 0.23%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$40.25 - $52.99 $4,025 - $5,299
-100 Reduced 1.18%
8,364 $347,000
Q1 2024

Apr 26, 2024

SELL
$47.98 - $54.4 $17,128 - $19,420
-357 Reduced 4.05%
8,464 $459,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $25,694 - $30,660
-530 Reduced 5.67%
8,821 $453,000
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $15,398 - $17,218
-266 Reduced 2.77%
9,351 $542,000
Q1 2023

May 16, 2023

SELL
$65.71 - $74.53 $582,716 - $660,932
-8,868 Reduced 47.97%
9,617 $667,000
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $25,543 - $30,246
-373 Reduced 1.98%
18,485 $1.33 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $1 - $768
10 Added 0.05%
18,858 $1.34 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $339,280 - $373,666
4,672 Added 32.96%
18,848 $1.45 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $298,178 - $357,542
4,850 Added 52.01%
14,176 $1.04 Million
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $135,630 - $158,113
-2,529 Reduced 21.33%
9,326 $581,000
Q3 2021

Dec 06, 2021

BUY
$59.17 - $69.31 $146,682 - $171,819
2,479 Added 26.44%
11,855 $701,000
Q1 2021

Jun 10, 2021

SELL
$59.34 - $66.74 $5,934 - $6,673
-100 Reduced 1.06%
9,376 $592,000
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $5,774 - $6,543
-100 Reduced 1.04%
9,476 $588,000
Q3 2020

Nov 30, 2020

BUY
$57.43 - $63.64 $5,743 - $6,364
100 Added 1.06%
9,576 $577,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $27,840 - $40,458
-600 Reduced 5.95%
9,476 $528,000
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $4,277 - $5,071
-100 Reduced 0.98%
10,076 $511,000
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $13,386 - $14,802
-300 Reduced 2.86%
10,176 $461,000
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $13,536 - $16,140
-300 Reduced 2.78%
10,476 $500,000
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $48,760 - $63,230
-1,000 Reduced 8.49%
10,776 $560,000
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $1,379 - $1,556
25 Added 0.21%
11,776 $731,000
Q1 2018

May 16, 2018

BUY
$59.92 - $68.98 $2,996 - $3,449
50 Added 0.43%
11,751 $743,000
Q4 2017

Feb 15, 2018

SELL
$59.94 - $65.35 $47,952 - $52,279
-800 Reduced 6.4%
11,701 $0
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $690,430 - $796,813
12,501
12,501 $797,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aspen Investment Management Inc Portfolio

Follow Aspen Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Investment Management Inc with notifications on news.